Prescribing Pre-Exposure Prophylaxis (PrEP) for HIV in WA general practice
On-demand recorded 30 Jun 2020
This webinar explores the strategies available for the prevention of HIV transmission, focusing on pre-exposure prophylaxis (PrEP). A landmark in HIV prevention drugs, PrEP (tenofovir with emtricitabine) is approved for use on the Pharmaceutical Benefits Scheme.
This webinar covers how to screen for PrEP eligibility, how to prescribe PrEP, and the best practice for monitoring patients on PrEP.
Delivered in partnership with the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).
- Describe different HIV prevention strategies
- Explain different options for PrEP dosing
- Use the PrEP decision making tool to manage patients on PrEP
- Explain the effectiveness and appropriate use of PrEP/PEP to patients
This event attracts 2 CPD points